Amanote Research
Register
Sign In
Utility of Percutaneous Liver Ablation in Patients With Metastatic Prostate Cancer
Journal of Vascular and Interventional Radiology
- United States
doi 10.1016/j.jvir.2015.12.324
Full Text
Open PDF
Abstract
Available in
full text
Categories
Nuclear Medicine
Radiology
Cardiology
Cardiovascular Medicine
Imaging
Medicine
Date
March 1, 2016
Authors
J. Christensen
A. Ashton
J. Ensor
S. Huang
R. Sheth
K. Ahrar
S. Gupta
A. Aparicio
B. Odisio
Publisher
Elsevier BV
Related search
Immune Analysis of Radium-223 in Patients With Metastatic Prostate Cancer
Clinical Genitourinary Cancer
Oncology
Urology
Managing Patients With Metastatic Prostate Cancer: Who Takes the Lead?
Trends in Urology & Men's Health
Longterm Survival Outcomes of Patients Undergoing Treatment With Radiofrequency Ablation for Hepatocellular Carcinoma and Metastatic Colorectal Cancer Liver Tumors
HPB
Hepatology
Gastroenterology
Therapeutic Efficacy Comparison of Radiofrequency Ablation in Hepatocellular Carcinoma and Metastatic Liver Cancer
Experimental and Therapeutic Medicine
Medicine
Cancer Research
Immunology
Microbiology
89Zr-huJ591 Immuno-Pet Imaging in Patients With Advanced Metastatic Prostate Cancer
European Journal of Nuclear Medicine and Molecular Imaging
Medicine
Nuclear Medicine
Radiology
Imaging
Healthcare Pathway and Costs Analysis in Patients With Metastatic Prostate Cancer (MPC)
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Liver Uptake on Bone Scan for Prostate Cancer Metastatic Workup
Clinical Case Reports
Medicine
STAMPEDE Trial and Patients With Non-Metastatic Prostate Cancer – Authors' Reply
The Lancet
Medicine
Thermal Ablation in the Management of Colorectal Cancer Patients With Oligometastatic Liver Disease
Visceral Medicine
Surgery
Gastroenterology
